Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas

  • Authors:
    • Kazushi Shigemasa
    • Xiurong Tian
    • Lijun Gu
    • Yuko Shiroyama
    • Nobutaka Nagai
    • Koso Ohama
  • View Affiliations

  • Published online on: January 1, 2003     https://doi.org/10.3892/ijo.22.1.99
  • Pages: 99-105
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

To investigate cyclooxygenase-2 (COX-2) expression and its relationship to p53 accumulation in ovarian adenocarcinomas, COX-2 and p53 protein expressions were examined by immunohistochemistry in 86 ovarian adenocarcinomas and six normal ovaries. In addition, COX-2 mRNA expression level was examined by semi-quantitative PCR in 36 ovarian adenocarcinomas. Neither COX-2 expression nor p53 accumulation were detected in normal ovarian surface epithelium or germinal inclusion cyst epithelial cells. In contrast, COX-2 protein expression was detected in 31.4% of adenocarcinomas, and p53 protein accumulation was found in 30.2% of adenocarcinomas. A significantly higher COX-2 expression rate was observed in endometrioid adenocarcinomas than in either mucinous (p=0.019) or clear cell (p=0.021) adenocarcinomas, and a significantly higher p53 accumulation rate was observed in serous adenocarcinomas compared to clear cell adenocarcinomas (p=0.015). p53 accumulation correlated with advanced clinical stage (stage I vs. stage II/III/IV: p=0.007), whereas no correlation was found between COX-2 expression and clinical stage. There was a significant positive correlation between COX-2 expression and p53 accumulation status (p=0.003). Log-rank testing showed that p53 accumulation was significantly correlated with poor patient survival (p=0.004), whereas no correlation was found between COX-2 expression and survival. COX-2 mRNA expression was detected in 72.2% of ovarian adenocarcinomas, and a significant correlation between COX-2 mRNA expression status and immunoreactivity (p=0.023) was observed. These results suggest that COX-2 expression might play an important role in ovarian cancer development and that COX-2 expression in ovarian adenocarcinomas is frequently associated with p53 protein accumulation. COX-2 overexpression in ovarian cancer cells might partly be caused by dysfunctional p53.

Related Articles

Journal Cover

January 2003
Volume 22 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shigemasa K, Tian X, Gu L, Shiroyama Y, Nagai N and Ohama K: Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas. Int J Oncol 22: 99-105, 2003.
APA
Shigemasa, K., Tian, X., Gu, L., Shiroyama, Y., Nagai, N., & Ohama, K. (2003). Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas. International Journal of Oncology, 22, 99-105. https://doi.org/10.3892/ijo.22.1.99
MLA
Shigemasa, K., Tian, X., Gu, L., Shiroyama, Y., Nagai, N., Ohama, K."Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas". International Journal of Oncology 22.1 (2003): 99-105.
Chicago
Shigemasa, K., Tian, X., Gu, L., Shiroyama, Y., Nagai, N., Ohama, K."Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas". International Journal of Oncology 22, no. 1 (2003): 99-105. https://doi.org/10.3892/ijo.22.1.99